Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues. - Wikidata - wikimedia - TriplyDB

Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues.

Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues.

http://www.wikidata.org/entity/Q36820693

about

Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids Assessment of reagents for selenocysteine conjugation and the stability of selenocysteine adducts.Stable and Potent Selenomab-Drug Conjugates.Utilization of Selenocysteine for Site-Specific Antibody Conjugation.Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.Chemical Protein Modification through Cysteine.Strategies and challenges for the next generation of antibody-drug conjugates.Irreversible Cysteine-Selective Protein Labeling Employing Modular Electrophilic Tetrafluoroethylation Reagents.Utilizing Selenocysteine for Expressed Protein Ligation and Bioconjugations.One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody-drug conjugates.Site-Specific Antibody Functionalization Using Tetrazine-Styrene Cycloaddition.

P2860

Q28076701-AEFFDF7D-A8EB-473E-813F-9491E4A197B6 Q36952323-38B97A54-7A35-4642-9F8A-1A4FC2D5E78E Q38432502-BDF3B32B-9EC9-42A1-B4FA-4497CD2653C6 Q38432937-EA0F082B-F485-41B8-9D44-2372D7308209 Q38665164-4DC181DA-5FF6-46CF-9E8E-8CE695E75C03 Q38704033-F3D95D56-3142-4B8E-A6DA-953FCE5115ED Q39182945-5664D29A-64EC-4D16-A62A-03B1CF9FB9E6 Q48240125-D7074B77-6DE8-42DF-AC53-1129F2975A5B Q48252519-F0DFF172-FC75-47B7-AB75-25961ADA94F7 Q48987144-A545A568-B2AB-4A8D-A50C-D60C85C7897C Q52691844-363CCD39-E97E-47B2-996F-3C6A0BE35AD8

P2860

Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues.

http://www.wikidata.org/entity/Q36820693

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Site-Specific Dual Antibody Co ...... e and Selenocysteine Residues.

@en

type

label

Site-Specific Dual Antibody Co ...... e and Selenocysteine Residues.

@en

prefLabel

Site-Specific Dual Antibody Co ...... e and Selenocysteine Residues.

@en

P1433

Q36820693-1ED1645F-9E26-4B25-B51E-EDA11FA0811B

P1476

Q36820693-1DDDD77E-84CA-4970-82AB-19B55E65383E

P2093

Q36820693-79D41960-10F1-468E-B230-98B86561BD0C

Q36820693-976EFC27-28CE-40E9-B120-2DE6D338DC86

Q36820693-9A7A4874-EE8F-4495-B3AC-F781CA6A6490

Q36820693-E1174142-72E7-49D3-8F72-7343790A4DA3

Q36820693-EBB03B46-7590-4965-A238-9AC149732114

P2860

Q36820693-075CBEA7-51DF-422B-B396-AADE0731AB58

Q36820693-3E51F51F-6244-4810-A672-A17E60FB5C1D

Q36820693-3F479EE0-A235-4B86-8778-6E0029C228AC

Q36820693-40EB47C4-10D6-4B28-9848-54C888241123

Q36820693-449A8480-2E13-4351-B538-F64F011A0B55

Q36820693-70080040-7D15-4A79-AABC-DFFCBE239659

Q36820693-76A934B0-6A55-409C-9669-E07207D3B14B

Q36820693-A43990CA-FF64-40F4-89E7-54BA27FDDDD3

Q36820693-A4D4BA81-EEBD-4B54-8B43-DE81393AAEBF

Q36820693-A7C928ED-43E3-495C-AA73-30EFF88176F6

P304

Q36820693-17E10395-EA08-457B-BB6C-E1E1E87E8ED3

P31

Q36820693-FD0A83DD-84F9-4D29-89DA-F14ED1878B94

P356

Q36820693-72C98AE6-0F52-41E4-BB4F-CB093171A850

P433

Q36820693-E4E8E3F2-4653-4D2D-BD61-E1ADABBFAB51

P478

Q36820693-15C9D82C-5FD9-473D-9B97-36D2C132E6B4

P50

Q36820693-4C069866-96A6-47AC-B1B6-866CA62E69B5

Q36820693-C55FF6E8-88C8-4EAC-8F73-2D6C8A835B21

P577

Q36820693-ECE6F781-889A-4BB2-AF30-C5EA4C98630A

P698

Q36820693-E61F79FC-C65D-4BD6-A8CA-165B7ADBBCCB

P921

Q36820693-0E1A4714-327B-4AA6-BC4D-545C46EDDF07

P932

Q36820693-5C0FA53F-97B3-4E2B-BA7D-954994EA9196

P356

ACS.BIOCONJCHEM.5B00244

P1433

Bioconjugate Chemistry

P1476

Site-Specific Dual Antibody Co ...... ne and Selenocysteine Residues

@en

P2093

Lee Pedzisa

http://www.w3.org/2001/XMLSchema#string

Mohosin Sarkar

http://www.w3.org/2001/XMLSchema#string

Thomas Kodadek

http://www.w3.org/2001/XMLSchema#string

William R Roush

http://www.w3.org/2001/XMLSchema#string

Xiuling Li

http://www.w3.org/2001/XMLSchema#string

P2860

Molecularly defined antibody conjugation through a selenocysteine interface.

Trastuzumab emtansine: mechanisms of action and drug resistance

Improving the serum stability of site-specific antibody conjugates with sulfone linkers.

Antibody-drug conjugates: targeted drug delivery for cancer.

Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.

Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development

Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.

An engineered selenocysteine defines a unique class of antibody derivatives.

Antibody conjugation via one and two C-terminal selenocysteines.

Site-specific antibody drug conjugates for cancer therapy

P304

2243-2248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.BIOCONJCHEM.5B00244

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Rader

James T Patterson

P577

2015-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26161903

http://www.w3.org/2001/XMLSchema#string

P921

L-selenocysteine

P932

4839195

http://www.w3.org/2001/XMLSchema#string